“…A large number of studies indicated the effectiveness of β-glucan against various diseases and disorders, and several applications reported in previous scientific work are the tendency to reduce onset of colorectal cancer (Dongowski et al, 2002), increased stool bulk and provide assistance against constipation (Odes et al, 1993;Valle-Jones, 1985), reduction in glycemic index (Cavallero et al, 2002;Jenkins et al, 2002;Granfeldt et al, 2008), flattening of the postprandial blood glucose levels and insulin rises (Hallfrisch et al, 2003;Li et al, 2003;Jenkins et al, 2002), prevention of insulin resistance (Brennan and Cleary, 2007;Hlebowicz et al, 2008), reduction in serum cholesterol levels (Delaney et al, 2003;Kang, et al, 2003;Kerckhoffs et al, 2003;Li et al, 2003;Yang et al, 2003;Smith et al, 2004), prevention of coronary heart disease (Jinshui et al, 2002), production of short-chain fatty acids (Wisker et al, 2000), prevention of hepatic damage by reducing taxol-induced hepatic damage (Karaduman et al, 2010), and promotion of the growth of beneficial gut microflora (Crittenden et al, 2002;Tungland, 2003).…”